Form 4: Surgery Partners Director and 10% Owner Acquires Over 6,800 Shares, Signaling Insider Confidence

Sentiment:

Insider Transaction Report


Blair E. Hendrix, a Director and 10% Owner of Surgery Partners, Inc. (SGRY), has acquired 6,861 shares of common stock, increasing his direct beneficial ownership.

Better than expectedThe acquisition of shares by a Director and 10% Owner is generally viewed as a positive indicator of insider confidence in the company's future performance and intrinsic value.

Summary

  • Blair E. Hendrix, identified as both a Director and a 10% Owner of Surgery Partners, Inc. (SGRY), acquired 6,861 shares of the company's common stock.
  • The transaction occurred on June 10, 2025, with the shares purchased at a price of $23.32 per share.
  • Following this acquisition, Mr. Hendrix's direct beneficial ownership in Surgery Partners, Inc. stands at 49,953,833 shares.
  • The newly acquired 6,861 shares are subject to a vesting period and will vest on June 10, 2026.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant insider purchase by a director and 10% owner, which typically signals strong confidence in the company's future prospects.

Positives

  • The acquisition of 6,861 shares by Blair E. Hendrix, a Director and 10% Owner, indicates strong insider confidence in the future performance and valuation of Surgery Partners, Inc.

Future Outlook

The acquired shares are set to vest on June 10, 2026, indicating a future milestone for the reporting person's ownership structure.

Industry Context

This Form 4 filing reflects an individual insider transaction and does not directly provide insights into broader industry trends within the healthcare services or surgical facility sectors. However, insider buying can be interpreted by the market as a positive signal for the company's specific prospects within its industry.

Related Party Transactions

  • The transaction involves Blair E. Hendrix, a Director and 10% Owner of Surgery Partners, Inc., acquiring shares from the company, which constitutes an insider transaction.

Stakeholder Impact

  • Shareholders may interpret this insider purchase as a positive signal, potentially increasing confidence in the company's stock.
  • The transaction directly impacts the beneficial ownership structure of a key insider.

Next Steps

  • The 6,861 acquired shares are scheduled to vest on June 10, 2026.

Key Dates

DateDescription
06/10/2025Date of common stock acquisition by Blair E. Hendrix.
06/12/2025Date the Form 4 filing was signed by Blair E. Hendrix.
06/10/2026Date when the acquired 6,861 shares will vest.

Recommendation

buy

Keywords

Surgery Partners, SGRY, Insider Trading, Stock Acquisition, Form 4, Director Purchase, 10% Owner, Common Stock, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.